V2P2 2022 - An Update in Advanced Prostate Cancer

Canadian Urological Association (CUA)

English - February 10, 2022 05:00 - 1 hour - 56.1 MB
Medicine Health & Fitness Science Life Sciences medicine urologic urology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Practice Changing Publications (PCP): Update in Kidney Cancer

Next Episode: CUA Practice Changing Publications (PCP) - Endourology (Surgical Management of BPH)

Disclosures:

Fred Saad
Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi

Eleni Efstathiou
Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation
Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant